These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 30668314)

  • 1. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.
    Wang L; Liu Y; Zhao TL; Li ZZ; He JY; Zhang BJ; Du HZ; Jiang JW; Yuan ST; Sun L
    Phytomedicine; 2019 Apr; 57():117-128. PubMed ID: 30668314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topotecan induces hepatocellular injury via ASCT2 mediated oxidative stress.
    Zhou G; Qin M; Zhang X; Yang J; Yu H
    Gastroenterol Hepatol; 2021 Jan; 44(1):1-12. PubMed ID: 33039171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth.
    Ye J; Huang Q; Xu J; Huang J; Wang J; Zhong W; Chen W; Lin X; Lin X
    J Cancer Res Clin Oncol; 2018 May; 144(5):821-833. PubMed ID: 29435734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.
    Lu H; Li X; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Oct; 381(1):23-30. PubMed ID: 27450723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobetyolin inhibits the proliferation of breast cancer cells
    Chen Y; Tian Y; Jin G; Cui Z; Guo W; Zhang X; Liu X
    Hum Exp Toxicol; 2021 Dec; 40(12):2074-2086. PubMed ID: 34075790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells.
    Luo Y; Li W; Ling Z; Hu Q; Fan Z; Cheng B; Tao X
    Cancer Med; 2020 May; 9(10):3489-3499. PubMed ID: 32162845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
    Zhang Z; Liu R; Shuai Y; Huang Y; Jin R; Wang X; Luo J
    Br J Cancer; 2020 Jan; 122(1):82-93. PubMed ID: 31819178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting ASCT2-mediated glutamine metabolism inhibits proliferation and promotes apoptosis of pancreatic cancer cells.
    Wang W; Pan H; Ren F; Chen H; Ren P
    Biosci Rep; 2022 Mar; 42(3):. PubMed ID: 35237783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
    Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
    Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.
    Wang Q; Hardie RA; Hoy AJ; van Geldermalsen M; Gao D; Fazli L; Sadowski MC; Balaban S; Schreuder M; Nagarajah R; Wong JJ; Metierre C; Pinello N; Otte NJ; Lehman ML; Gleave M; Nelson CC; Bailey CG; Ritchie W; Rasko JE; Holst J
    J Pathol; 2015 Jul; 236(3):278-89. PubMed ID: 25693838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
    Cormerais Y; Massard PA; Vucetic M; Giuliano S; Tambutté E; Durivault J; Vial V; Endou H; Wempe MF; Parks SK; Pouyssegur J
    J Biol Chem; 2018 Feb; 293(8):2877-2887. PubMed ID: 29326164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pro-proliferative effect of interferon-γ in breast cancer cell lines is dependent on stimulation of ASCT2-mediated glutamine cellular uptake.
    Silva C; Andrade N; Rodrigues I; Ferreira AC; Soares ML; Martel F
    Life Sci; 2021 Dec; 286():120054. PubMed ID: 34662550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AP1G1 is involved in cetuximab-mediated downregulation of ASCT2-EGFR complex and sensitization of human head and neck squamous cell carcinoma cells to ROS-induced apoptosis.
    Tao X; Lu Y; Qiu S; Wang Y; Qin J; Fan Z
    Cancer Lett; 2017 Nov; 408():33-42. PubMed ID: 28823958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
    Ji YB; Zhou JH; Zuo MX; You QD
    Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of ASCT2 gene knock-down by shRNA on biological behaviors of colorectal cancer cells].
    Cai C; Zeng B; Zeng J; Xin H; Tang C
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):450-454. PubMed ID: 28440528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS-mutated human colorectal cancer cells.
    Hara Y; Minami Y; Yoshimoto S; Hayashi N; Yamasaki A; Ueda S; Masuko K; Masuko T
    Cancer Med; 2020 Jan; 9(1):302-312. PubMed ID: 31709772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
    van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JE; Holst J
    Oncogene; 2016 Jun; 35(24):3201-8. PubMed ID: 26455325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobetyolin induces apoptosis of colon cancer cells by inhibiting glutamine metabolism.
    He W; Tao W; Zhang F; Jie Q; He Y; Zhu W; Tan J; Shen W; Li L; Yang Y; Cheng H; Sun D
    J Cell Mol Med; 2020 Mar; 24(6):3359-3369. PubMed ID: 31990147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol enhances cisplatin-induced apoptosis in human hepatoma cells via glutamine metabolism inhibition.
    Liu Z; Peng Q; Li Y; Gao Y
    BMB Rep; 2018 Sep; 51(9):474-479. PubMed ID: 30103844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors via the transporter ASCT2.
    Zhou P; Liang X; Zhou C; Qin J; Hou C; Zhu Z; Zhang W; Wang S; Zhong D
    J Mater Chem B; 2019 Sep; 7(35):5363-5375. PubMed ID: 31403158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.